These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17908966)

  • 21. [Epidermal growth factor receptor mutation in Chinese patients with non-small cell lung cancer].
    Pan ZK; Zhang L; Zhang X; Wang X; Li N; Xu F; Chang JH; Guan ZZ
    Ai Zheng; 2005 Aug; 24(8):919-23. PubMed ID: 16086866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical course of patients with non-small cell lung cancer and epidermal growth factor receptor exon 19 and exon 21 mutations treated with gefitinib or erlotinib.
    Riely GJ; Pao W; Pham D; Li AR; Rizvi N; Venkatraman ES; Zakowski MF; Kris MG; Ladanyi M; Miller VA
    Clin Cancer Res; 2006 Feb; 12(3 Pt 1):839-44. PubMed ID: 16467097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between epidermal growth factor receptor gene mutations and clinicopathological features in patients with non-small cell lung cancer in western Turkey.
    Unal OU; Oztop I; Calibasi G; Baskin Y; Koca D; Demir N; Akman T; Ellidokuz H; Yilmaz AU
    Asian Pac J Cancer Prev; 2013; 14(6):3705-9. PubMed ID: 23886169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutations within the tyrosine kinase domain of EGFR gene specifically occur in lung adenocarcinoma patients with a low exposure of tobacco smoking.
    Sugio K; Uramoto H; Ono K; Oyama T; Hanagiri T; Sugaya M; Ichiki Y; So T; Nakata S; Morita M; Yasumoto K
    Br J Cancer; 2006 Mar; 94(6):896-903. PubMed ID: 16552419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Relationship between mutations of epidermal growth factor receptor gene and clinicopathologic features of non-small cell lung cancers].
    Wang F; Fu S; Tang T; Deng L; Zhang X; Li YZ; Shao JY
    Zhonghua Bing Li Xue Za Zhi; 2011 Oct; 40(10):664-6. PubMed ID: 22321543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of Smoking and Brain Metastasis on Outcomes of Advanced EGFR Mutation Lung Adenocarcinoma Patients Treated with First Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.
    Jain A; Lim C; Gan EM; Ng DZ; Ng QS; Ang MK; Takano A; Chan KS; Tan WM; Kanesvaran R; Toh CK; Loo CM; Hsu AA; Devanand A; Lim CH; Koong HN; Koh T; Fong KW; Yap SP; Kim SW; Chowbay B; Oon L; Lim KH; Lim WT; Tan EH; Tan DS
    PLoS One; 2015; 10(5):e0123587. PubMed ID: 25955322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection and comparison of peptide nucleic acid-mediated real-time polymerase chain reaction clamping and direct gene sequencing for epidermal growth factor receptor mutations in patients with non-small cell lung cancer.
    Kim HJ; Lee KY; Kim YC; Kim KS; Lee SY; Jang TW; Lee MK; Shin KC; Lee GH; Lee JC; Lee JE; Kim SY
    Lung Cancer; 2012 Mar; 75(3):321-5. PubMed ID: 21930325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spectrum of EGFR gene mutations in Vietnamese patients with non-small cell lung cancer.
    Vu HA; Xinh PT; Ha HT; Hanh NT; Bach ND; Thao DT; Dat NQ; Trung NS
    Asia Pac J Clin Oncol; 2016 Mar; 12(1):86-90. PubMed ID: 26707566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical features reflect exon sites of EGFR mutations in patients with resected non-small-cell lung cancer.
    Na II; Rho JK; Choi YJ; Kim CH; Koh JS; Ryoo BY; Yang SH; Lee JC
    J Korean Med Sci; 2007 Jun; 22(3):393-9. PubMed ID: 17596643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Higher TP53 somatic mutation prevalence from liquid biopsy analysis in ever smoker non-small-cell lung cancer patients.
    Erdem HB; Alay MT; Özdemir Z; Çevik E; Ateş Ö; Karaçin C; Şahin İ; Doğan M; Bahsi T
    Mutat Res; 2024; 828():111847. PubMed ID: 38071953
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overall Survival Analysis and Characterization of an EGFR Mutated Non-Small Cell Lung Cancer (NSCLC) Population.
    Aguiar F; Fernandes G; Queiroga H; Machado JC; Cirnes L; Souto Moura C; Hespanhol V
    Arch Bronconeumol (Engl Ed); 2018 Jan; 54(1):10-17. PubMed ID: 29079040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Mutations in exon 19 of EGFR gene in non-small cell lung cancer from Chinese patients].
    Wang HY; Luo H; Zhao YM; Tang L; Zhou CC
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Jun; 25(3):315-8. PubMed ID: 18543225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of smoking status on the progression-free survival of non-small cell lung cancer patients harboring activating epidermal growth factor receptor (EGFR) mutations receiving first-line EGFR tyrosine kinase inhibitor versus platinum doublet chemotherapy: a meta-analysis of prospective randomized trials.
    Hasegawa Y; Ando M; Maemondo M; Yamamoto S; Isa S; Saka H; Kubo A; Kawaguchi T; Takada M; Rosell R; Kurata T; Ou SH
    Oncologist; 2015 Mar; 20(3):307-15. PubMed ID: 25657199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advanced Non-small Cell Lung Cancer: EGFR Mutation Analysis Using Pyrosequencing and the Fully Automated qPCR-Based Idylla
    Boustany Y; Laraqui A; El Zaitouni S; Ghaouti M; Benzekri A; Kettani F; Oukabli M; Ennibi K; Belkadi B; Sekhsokh Y
    Cancer Control; 2023; 30():10732748231177538. PubMed ID: 37196225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences in epidermal growth factor receptor gene mutations and relationship with clinicopathological features in NSCLC between Uygur and Han ethnic groups.
    Zhang Y; Wang Q; Han ZG; Shan L
    Asian Pac J Cancer Prev; 2013; 14(5):2879-83. PubMed ID: 23803047
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of cigarette-smoking history to estimate the likelihood of mutations in epidermal growth factor receptor gene exons 19 and 21 in lung adenocarcinomas.
    Pham D; Kris MG; Riely GJ; Sarkaria IS; McDonough T; Chuai S; Venkatraman ES; Miller VA; Ladanyi M; Pao W; Wilson RK; Singh B; Rusch VW
    J Clin Oncol; 2006 Apr; 24(11):1700-4. PubMed ID: 16505411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Epidermal growth factor receptor gene mutations and clinicopathologic correlation in 309 patients with non-small cell lung cancer].
    Feng Q; Li XH; Chen Z; He JS; Wang CX; Zhou LX; Xue WC
    Zhonghua Bing Li Xue Za Zhi; 2011 Oct; 40(10):660-3. PubMed ID: 22321542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinicopathologic significance of the mutations of the epidermal growth factor receptor gene in patients with non-small cell lung cancer.
    Tomizawa Y; Iijima H; Sunaga N; Sato K; Takise A; Otani Y; Tanaka S; Suga T; Saito R; Ishizuka T; Dobashi K; Minna JD; Nakajima T; Mori M
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6816-22. PubMed ID: 16203769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidermal growth factor receptor mutation status is strongly associated with smoking status in patients undergoing surgical resection for lung adenocarcinoma.
    Matsumura Y; Owada Y; Inoue T; Watanabe Y; Yamaura T; Fukuhara M; Muto S; Okabe N; Hasegawa T; Hoshino M; Osugi J; Higuchi M; Suzuki H
    Interact Cardiovasc Thorac Surg; 2017 Nov; 25(5):690-695. PubMed ID: 29049789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Analysis of EGFR mutations in 176 cases of non-small cell lung cancer].
    Dong QG; Han BH; Huang JS; Yang LM; Huang J; Zhao CY; Lu LQ
    Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):686-90. PubMed ID: 17274376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.